News

Filter

1 to 9 of 27 results

Ipsen's revenues up 6% on new US launches

09-02-2009

French drugmaker Ipsen has reported sales figures for the full year 2008 showing reduced revenue in its…

Abobotulinumtoxin A InjectionAlendronate SodiumApokynApomorphineDysportFosamaxIncrelexIpsenMecasermin [rDNA origin] InjectionNutropinNutropin AQNutropin DepotSerostimSomatropinTrelstarTrelstar LAtriptorelin pamoate

Ipsen reports 8.4% sales growth in 1st qtr

12-05-2008

Paris, France-based Ipsen announced strong first-quarter results for 2008, featuring an 8.4% increase…

Abobotulinumtoxin A InjectionAlendronate SodiumDiovanDysportFosamaxIncrelexIpsenMecasermin [rDNA origin] InjectionNutropinNutropin AQNutropin DepotSerostimSomatropinvalsartan

Tercica begins dosing in Ph II IGF-1 deficiency trial

04-02-2008

California, USA-based biopharmaceutical firm Tercica says it has initiated dosing in a Phase II trial…

Antihemophilic FactorCoagulation Factor VIIaGenentechHumulin 70-30Humulin NHumulin RIncrelexInsulinMecasermin [rDNA origin] InjectionNutropinNutropin AQNutropin DepotRecombinantSerostimSomatropin

Ipsen/Tercica's Increlex approved in Europe

20-08-2007

French drugmaker Ipsen says that the European Commission has granted marketing authorization for Increlex…

Antihemophilic FactorCoagulation Factor VIIaHumulin 70-30Humulin NHumulin RIncrelexInsulinIpsenMecasermin [rDNA origin] InjectionRecombinant

1 to 9 of 27 results

COMPANY SPOTLIGHT

Menarini

Back to top